Sponsored by
News
MTX to build Royal Surrey’s Cancer and Surgical Innovation Centre
Modern methods of construction specialist MTX has been awarded the contract to deliver Royal Surrey County Hospital’s Cancer and Surgical Innovation Centre, which will offer state-of-the-art facilities and include six new operating theatres. The £41.5m two-storey development will build on
Royal Surrey County Hospital’s world-class services in robotic and non-robotic surgery and enable an additional 7,000 patients to receive surgery every year. The investment in new facilities will help Royal Surrey respond to increasing demand for cancer surgery and bring down waiting lists for all elective (planned) surgical procedures. MTX employs modern methods of construction
(MMC) and Design for Manufacture and Assembly (DfMA) principles to deliver new facilities faster, safer, greener and more cost effectively than conventional building methods. The fast-track processes enable ground works
to take place on site while precisely engineered structural steel units are factory manufactured offsite for delivery and installation. The result is a reduction in programme duration and earlier delivery of new facilities that are purpose-designed and fully compliant to more quicky benefit patients and help to reduce waiting lists. Work has already begun on site. MTX Pre-Construction Director Mike Butler explained: “MTX has a proven track record in supporting NHS Trusts in the delivery of vitally needed new facilities and we are delighted to be partnering the Royal Surrey to create this exciting new Cancer and Surgical Centre. “Our expertise and resources support our Trust partners at every step of the journey from concept design, through to completion and handover, to
ensure each facility is fully compliant and a resource that will deliver a rapid return on investment for the Trust, and enhanced services for patients.” Royal Surrey NHS Foundation Trust Deputy Chief Executive, Ross Dunworth, said: “We are pleased to have awarded the contract for this major development to MTX who have extensive experience of similar construction at other NHS Trusts. The new Cancer and Surgical Innovation Centre will be a huge step forward for Royal Surrey and transform the care we are able to provide to our patients. “Many members of staff, patients, visitors and
our charitable supporters are closely following the progress with ground works on site and updates on the units being built off site. There is a shared sense of excitement around this £40m plus development and we are very much looking
forward to opening and using the new centre.” The new Cancer and Surgical Innovation Centre
will link to the main hospital and its existing operating theatres. It will serve as the main entrance for surgical patients attending the hospital with the exception of paediatric and day surgery patients, which will remain as a separate unit in its current location. The new facility will replace Royal Surrey’s ageing Surgical Short Stay Unit. Royal Surrey is one of the largest cancer centres in the country. A total of 60 per cent of all surgeries performed at Royal Surrey are cancer related surgeries and the Trust supports a large catchment area across the South East of England and beyond of up to three million people - just under five per cent of the UK’s population.
Major robotic-assisted surgery milestone for Scotland
More than 10,000 patients across Scotland have benefitted from da Vinci robotic-assisted surgery (RAS) since 2021, following a major expansion of da Vinci surgical systems which was designed to reduce rates of open surgery, improve equity of access and outcomes for patients, and enhance NHS productivity. The expansion saw the Scottish Government invest in 12 additional da Vinci surgical systems since 2021, more than tripling the number of existing da Vinci surgical systems in the country. It had the primary aim of improving access to RAS for gynaecology and colorectal patients, the clinical specialties that had the highest rates of open surgery in Scotland. It also supported continued expansion in the already established programmes of urology,
thoracic, and head and neck surgery. As a result, more patients in Scotland have been able to benefit from minimally invasive surgery, with the improved outcomes associated with da Vinci RAS, such as quicker recovery times, fewer complications, and a reduced chance of readmission, helping to improve productivity across Scotland. Professor Campbell Roxburgh, Consultant
Colorectal Surgeon, University of Glasgow, said: “Thanks to the Scottish Government’s continued investment in this cutting edge technology and its ongoing implementation across the nation, we are now realising what we set out to achieve through the expansion – we have vastly reduced rates of open surgery and we have improved equity of access to robotic-assisted surgery and
its associated outcomes for patients. To reach this significant national milestone is testament to that.” Improved access to da Vinci RAS has been
helping to support national healthcare ambitions, forming a key component of the Scottish Cancer Action Plan for 2023-2026. Health Secretary, Neil Gray, said: “These surgical
robots have transformed the experience of surgery for a number of patients across NHS Scotland, as well as easing the pressure on surgeons, with procedures that are less physically demanding to carry out. Crucially, by providing more opportunities for surgeons to carry out robotic-assisted procedures we can attract a broader pool of surgeons to work here, helping us build a stronger NHS Scotland for the future.”
March 2025 I
www.clinicalservicesjournal.com 11
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
